As a result, these advantages (illustrated in Figure 2 ) give hope that, in the following years, there will be a significant trend toward the creation, improvement, pre-clinical and clinical testing of protocols for the nanotechnology-mediated delivery of miRNA-drugs. 3 Emerging applications of nanotechnologies for miRNA-mediated cancer therapeutics 3.1 Breast cancer Breast cancer is a heterogeneous disease distinguished by the growth of malignant tumors in mammary glands ( Heer et al., 2020 ).
← all excerpts
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives.
1
—
—